Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000008

CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (option exercise)

  • CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Option exercise 10b5-1 +11,817 $0.34 $4,018 240,777 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Conversion 10b5-1 −11,817 228,960 D
Derivatives
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Option exercise · Share Option (right to buy) 10b5-1 −11,817 142,898 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Conversion · American Depositary Shares 10b5-1 +3,939 3,939 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Sale · American Depositary Shares 10b5-1 −3,020 $53.13 $160,462 919 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Sale · American Depositary Shares 10b5-1 −519 $54.20 $28,128 400 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-08-18 Sale · American Depositary Shares 10b5-1 −400 $55.05 $22,020 0 D
Loading xslF345X06/form4-08202026_120854.xml…